Align for the future with Myval THV series - From randomised trials to everyday clinical practice

Sponsored by Meril Life

Spokesperson: A. Baumbach

Discussants: C. Gandolfo, G. Sengottuvelu, M. De Carlo

Summary

Through the presentation of several compelling cases, including an 88-year-old male with CKD, RBBB, moderate LV dysfunction, and severe aortic stenosis, a Type 1a bicuspid native AS, and an extraordinary TAVI in an 83-year-old with acute heart failure and comorbidities, this session will dive into the Myval Octapro THV. Learn about its key features, procedural impact, and potential clinical benefits. Discover the Octalign technique for predictable and precise commissural and coronary alignment, preserving coronary access. Gain insights into precise sizing, positioning, and deployment of the Myval THV series in real-world scenarios, and explore the relevance of pivotal Landmark RCTs in clinical practice.

Learning Objectives

To know more about pivotal Landmark randomised controlled trial and its relevance in clinical practice
To learn about the novel Myval Octapro THV - Key features, the procedural impact and potential clinical benefits.
To know the Octalign technique which enables predictable and precise commissural and coronary alignment thus preserving coronary access
To understand the technique of precise sizing, positioning and deployment of Myval THV series in real world clinical scenarios